SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2wnb'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1D4F_B_ADNB602_2 (S-ADENOSYLHOMOCYSTEI NE HYDROLASE)	2wnb	- (Sus scrofa)	4 / 5	THR A 224 THR A 225 GLU A 122 THR A 119	None	1.37A	1d4fB-2wnbA: undetectable	1d4fB-2wnbA: 21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICR_A_NIOA604_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	SER A 325 THR A 328 PHE A 292 GLY A 273	None None C5P A1344 (-4.6A) C5P A1344 (-3.2A)	1.30A	1icrA-2wnbA: undetectable 1icrB-2wnbA: undetectable	1icrA-2wnbA: 20.77 1icrB-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICR_B_NIOB602_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	GLY A 273 SER A 325 THR A 328 PHE A 292	C5P A1344 (-3.2A) None None C5P A1344 (-4.6A)	1.26A	1icrA-2wnbA: undetectable 1icrB-2wnbA: undetectable	1icrA-2wnbA: 20.77 1icrB-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICU_D_NIOD223_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	GLY A 273 SER A 325 THR A 328 PHE A 292	C5P A1344 (-3.2A) None None C5P A1344 (-4.6A)	1.36A	1icuC-2wnbA: undetectable 1icuD-2wnbA: undetectable	1icuC-2wnbA: 20.77 1icuD-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICV_B_NIOB702_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	GLY A 273 SER A 325 THR A 328 PHE A 292	C5P A1344 (-3.2A) None None C5P A1344 (-4.6A)	1.33A	1icvA-2wnbA: undetectable 1icvB-2wnbA: undetectable	1icvA-2wnbA: 20.77 1icvB-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICV_C_NIOC708_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	SER A 325 THR A 328 PHE A 292 GLY A 273	None None C5P A1344 (-4.6A) C5P A1344 (-3.2A)	1.31A	1icvC-2wnbA: undetectable 1icvD-2wnbA: undetectable	1icvC-2wnbA: 20.77 1icvD-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ICV_D_NIOD706_1 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	GLY A 273 SER A 325 THR A 328 PHE A 292	C5P A1344 (-3.2A) None None C5P A1344 (-4.6A)	1.29A	1icvC-2wnbA: undetectable 1icvD-2wnbA: undetectable	1icvC-2wnbA: 20.77 1icvD-2wnbA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1KQB_B_BEZB525_0 (OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE)	2wnb	- (Sus scrofa)	4 / 5	GLY A 273 SER A 325 THR A 328 PHE A 292	C5P A1344 (-3.2A) None None C5P A1344 (-4.6A)	1.32A	1kqbA-2wnbA: undetectable 1kqbB-2wnbA: undetectable	1kqbA-2wnbA: 21.61 1kqbB-2wnbA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SV9_A_DIFA701_1 (PHOSPHOLIPASE A2)	2wnb	- (Sus scrofa)	5 / 8	LEU A 263 ILE A 278 GLY A 273 HIS A 319 PHE A 212	None None C5P A1344 (-3.2A) GAL A1347 (-3.9A) GAL A1347 (-3.9A)	1.46A	1sv9A-2wnbA: undetectable	1sv9A-2wnbA: 14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1V54_B_CHDB4085_0 (CYTOCHROME C OXIDASE POLYPEPTIDE I CYTOCHROME C OXIDASE POLYPEPTIDE II CYTOCHROME C OXIDASE POLYPEPTIDE VIA-HEART)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.48A	1v54A-2wnbA: 0.0 1v54B-2wnbA: 0.0 1v54T-2wnbA: 0.0	1v54A-2wnbA: 17.88 1v54B-2wnbA: 18.98 1v54T-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B17_A_DIFA701_1 (PHOSPHOLIPASE A2 VRV-PL-VIIIA)	2wnb	- (Sus scrofa)	5 / 10	LEU A 263 ILE A 278 GLY A 273 HIS A 319 PHE A 212	None None C5P A1344 (-3.2A) GAL A1347 (-3.9A) GAL A1347 (-3.9A)	1.46A	2b17A-2wnbA: undetectable	2b17A-2wnbA: 14.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZXW_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE 7A1 CYTOCHROME C OXIDASE SUBUNIT 1)	2wnb	- (Sus scrofa)	4 / 7	ILE A 68 LEU A 281 PHE A 81 ARG A 60	None	1.15A	2zxwN-2wnbA: undetectable 2zxwW-2wnbA: undetectable	2zxwN-2wnbA: 17.88 2zxwW-2wnbA: 11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ABK_O_CHDO229_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.48A	3abkG-2wnbA: 0.0 3abkN-2wnbA: undetectable 3abkO-2wnbA: 0.0	3abkG-2wnbA: 14.73 3abkN-2wnbA: 17.88 3abkO-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG3_O_CHDO229_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 11	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.48A	3ag3G-2wnbA: undetectable 3ag3N-2wnbA: undetectable 3ag3O-2wnbA: undetectable	3ag3G-2wnbA: 14.73 3ag3N-2wnbA: 17.88 3ag3O-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_B_CHDB1085_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 12	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.49A	3ag4A-2wnbA: 0.0 3ag4B-2wnbA: 0.0 3ag4T-2wnbA: 0.0	3ag4A-2wnbA: 17.88 3ag4B-2wnbA: 18.98 3ag4T-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3AG4_O_CHDO229_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.49A	3ag4G-2wnbA: 0.0 3ag4N-2wnbA: 0.0 3ag4O-2wnbA: 0.0	3ag4G-2wnbA: 14.73 3ag4N-2wnbA: 17.88 3ag4O-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_B_CHDB1085_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.45A	3asnA-2wnbA: 0.0 3asnB-2wnbA: 0.0 3asnT-2wnbA: 0.0	3asnA-2wnbA: 17.88 3asnB-2wnbA: 18.98 3asnT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_B_CHDB1085_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.46A	3asoA-2wnbA: 0.0 3asoB-2wnbA: 0.0 3asoT-2wnbA: 0.0	3asoA-2wnbA: 17.88 3asoB-2wnbA: 18.98 3asoT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OI8_A_ADNA2_1 (UNCHARACTERIZED PROTEIN)	2wnb	- (Sus scrofa)	4 / 6	ILE A 120 HIS A 251 PRO A 211 LEU A 217	None	1.18A	3oi8A-2wnbA: undetectable	3oi8A-2wnbA: 22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3U9F_K_CLMK221_0 (CHLORAMPHENICOL ACETYLTRANSFERASE)	2wnb	- (Sus scrofa)	5 / 10	PHE A 192 TYR A 250 PHE A 254 LEU A 289 VAL A 287	None	1.41A	3u9fK-2wnbA: undetectable	3u9fK-2wnbA: 19.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W67_A_VIVA301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	2wnb	- (Sus scrofa)	5 / 11	LEU A 201 ILE A 208 VAL A 193 PHE A 198 VAL A 220	None	0.90A	3w67A-2wnbA: undetectable	3w67A-2wnbA: 24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W68_A_VIVA301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	2wnb	- (Sus scrofa)	5 / 12	LEU A 201 ILE A 208 VAL A 193 PHE A 198 VAL A 220	None	0.99A	3w68A-2wnbA: undetectable	3w68A-2wnbA: 24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W68_D_VIVD301_0 (ALPHA-TOCOPHEROL TRANSFER PROTEIN)	2wnb	- (Sus scrofa)	5 / 12	LEU A 201 ILE A 208 VAL A 193 PHE A 198 VAL A 220	None	0.98A	3w68D-2wnbA: undetectable	3w68D-2wnbA: 24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_B_CHDB303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.43A	3wg7A-2wnbA: 0.0 3wg7B-2wnbA: 0.0 3wg7T-2wnbA: 0.0	3wg7A-2wnbA: 17.88 3wg7B-2wnbA: 18.98 3wg7T-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_G_CHDG103_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.46A	3wg7G-2wnbA: 0.0 3wg7N-2wnbA: 0.0 3wg7O-2wnbA: 0.0	3wg7G-2wnbA: 14.73 3wg7N-2wnbA: 17.88 3wg7O-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3X2Q_B_CHDB302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.50A	3x2qA-2wnbA: 0.0 3x2qB-2wnbA: 0.0 3x2qT-2wnbA: 0.0	3x2qA-2wnbA: 17.88 3x2qB-2wnbA: 18.98 3x2qT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4MK4_B_CHDB502_0 (FERROCHELATASE, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	4 / 6	PHE A 279 ILE A 283 ARG A 143 VAL A 131	None	1.01A	4mk4B-2wnbA: undetectable	4mk4B-2wnbA: 21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OBW_D_SAMD601_0 (2-METHOXY-6-POLYPREN YL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 12	ALA A 91 GLY A 129 ILE A 120 ASN A 117 ASN A 93	None	1.25A	4obwD-2wnbA: undetectable	4obwD-2wnbA: 20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QZU_C_ACTC202_0 (RETINOL-BINDING PROTEIN 2)	2wnb	- (Sus scrofa)	4 / 6	TYR A 101 GLU A 218 THR A 119 LEU A 105	None	1.44A	4qzuC-2wnbA: undetectable	4qzuC-2wnbA: 17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1A_B_CHDB303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.45A	5b1aA-2wnbA: 0.0 5b1aB-2wnbA: 0.0 5b1aT-2wnbA: 0.0	5b1aA-2wnbA: 17.88 5b1aB-2wnbA: 18.98 5b1aT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I8F_A_ML1A210_1 (PHENOLIC OXIDATIVE COUPLING PROTEIN)	2wnb	- (Sus scrofa)	5 / 12	LEU A 331 LEU A 263 VAL A 258 TYR A 250 GLY A 273	None None None None C5P A1344 (-3.2A)	1.42A	5i8fA-2wnbA: undetectable	5i8fA-2wnbA: 21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IY5_G_CHDG102_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.48A	5iy5G-2wnbA: 0.0 5iy5N-2wnbA: 0.0 5iy5O-2wnbA: 0.0	5iy5G-2wnbA: 14.78 5iy5N-2wnbA: 17.88 5iy5O-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0O_A_SAMA501_0 (PEPTIDE N-METHYLTRANSFERASE)	2wnb	- (Sus scrofa)	5 / 12	ILE A 278 VAL A 147 SER A 276 PHE A 292 VAL A 327	None None None C5P A1344 (-4.6A) None	1.16A	5n0oA-2wnbA: undetectable	5n0oA-2wnbA: 22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0S_B_SAMB501_0 (PEPTIDE N-METHYLTRANSFERASE)	2wnb	- (Sus scrofa)	5 / 12	ILE A 278 VAL A 147 SER A 276 PHE A 292 VAL A 327	None None None C5P A1344 (-4.6A) None	1.18A	5n0sB-2wnbA: undetectable	5n0sB-2wnbA: 22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ND3_B_TA1B601_1 (TUBULIN BETA-2B CHAIN)	2wnb	- (Sus scrofa)	5 / 12	VAL A 242 GLU A 200 LEU A 217 LEU A 209 THR A 215	None	1.26A	5nd3B-2wnbA: undetectable	5nd3B-2wnbA: 20.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5W97_B_CHDB303_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.49A	5w97A-2wnbA: 0.0 5w97B-2wnbA: 0.0 5w97g-2wnbA: 0.0	5w97A-2wnbA: 17.88 5w97B-2wnbA: 18.98 5w97g-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X1F_G_CHDG104_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.48A	5x1fG-2wnbA: 0.0 5x1fN-2wnbA: 0.0 5x1fO-2wnbA: 0.0	5x1fG-2wnbA: 14.73 5x1fN-2wnbA: 17.88 5x1fO-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_B_CHDB304_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.49A	5xdqA-2wnbA: 0.0 5xdqB-2wnbA: 0.0 5xdqT-2wnbA: 0.0	5xdqA-2wnbA: 17.88 5xdqB-2wnbA: 18.98 5xdqT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDQ_G_CHDG102_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.48A	5xdqG-2wnbA: 0.0 5xdqN-2wnbA: 0.0 5xdqO-2wnbA: 0.0	5xdqG-2wnbA: 14.73 5xdqN-2wnbA: 17.88 5xdqO-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_B_CHDB302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.49A	5xdxA-2wnbA: 0.0 5xdxB-2wnbA: 0.0 5xdxT-2wnbA: 0.0	5xdxA-2wnbA: 17.88 5xdxB-2wnbA: 18.98 5xdxT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XDX_O_CHDO301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.46A	5xdxG-2wnbA: 0.0 5xdxN-2wnbA: 0.0 5xdxO-2wnbA: 0.0	5xdxG-2wnbA: 14.73 5xdxN-2wnbA: 17.88 5xdxO-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_B_CHDB302_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.49A	5zcoA-2wnbA: 0.0 5zcoB-2wnbA: 0.0 5zcoT-2wnbA: 0.0	5zcoA-2wnbA: 17.88 5zcoB-2wnbA: 18.98 5zcoT-2wnbA: 14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCO_G_CHDG102_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 10	ARG A 171 PHE A 192 GLY A 273 GLY A 291 THR A 328	None None C5P A1344 (-3.2A) None None	1.49A	5zcoG-2wnbA: 0.0 5zcoN-2wnbA: 0.0 5zcoO-2wnbA: 0.0	5zcoG-2wnbA: 14.73 5zcoN-2wnbA: 17.88 5zcoO-2wnbA: 18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZCP_B_CHDB301_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 2 CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL)	2wnb	- (Sus scrofa)	5 / 11	GLY A 291 THR A 328 ARG A 171 PHE A 192 GLY A 273	None None None None C5P A1344 (-3.2A)	1.50A	5zcpA-2wnbA: 0.0 5zcpB-2wnbA: 0.0 5zcpT-2wnbA: 0.0	5zcpA-2wnbA: 17.88 5zcpB-2wnbA: 18.98 5zcpT-2wnbA: 14.73

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1D4F_B_ADNB602_2","S-ADENOSYLHOMOCYSTEINE HYDROLASE","2wnb","-","Sus scrofa",4,"THR A 224;THR A 225;GLU A 122;THR A 119","None","1.37A","1d4fB-2wnbA:undetectable","1d4fB-2wnbA:21.75"],["1ICR_A_NIOA604_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"SER A 325;THR A 328;PHE A 292;GLY A 273","None;None;C5P A1344 (-4.6A);C5P A1344 (-3.2A)","1.30A","1icrA-2wnbA:undetectable;1icrB-2wnbA:undetectable","1icrA-2wnbA:20.77;1icrB-2wnbA:20.77"],["1ICR_B_NIOB602_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"GLY A 273;SER A 325;THR A 328;PHE A 292","C5P A1344 (-3.2A);None;None;C5P A1344 (-4.6A)","1.26A","1icrA-2wnbA:undetectable;1icrB-2wnbA:undetectable","1icrA-2wnbA:20.77;1icrB-2wnbA:20.77"],["1ICU_D_NIOD223_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"GLY A 273;SER A 325;THR A 328;PHE A 292","C5P A1344 (-3.2A);None;None;C5P A1344 (-4.6A)","1.36A","1icuC-2wnbA:undetectable;1icuD-2wnbA:undetectable","1icuC-2wnbA:20.77;1icuD-2wnbA:20.77"],["1ICV_B_NIOB702_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"GLY A 273;SER A 325;THR A 328;PHE A 292","C5P A1344 (-3.2A);None;None;C5P A1344 (-4.6A)","1.33A","1icvA-2wnbA:undetectable;1icvB-2wnbA:undetectable","1icvA-2wnbA:20.77;1icvB-2wnbA:20.77"],["1ICV_C_NIOC708_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"SER A 325;THR A 328;PHE A 292;GLY A 273","None;None;C5P A1344 (-4.6A);C5P A1344 (-3.2A)","1.31A","1icvC-2wnbA:undetectable;1icvD-2wnbA:undetectable","1icvC-2wnbA:20.77;1icvD-2wnbA:20.77"],["1ICV_D_NIOD706_1","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE;OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"GLY A 273;SER A 325;THR A 328;PHE A 292","C5P A1344 (-3.2A);None;None;C5P A1344 (-4.6A)","1.29A","1icvC-2wnbA:undetectable;1icvD-2wnbA:undetectable","1icvC-2wnbA:20.77;1icvD-2wnbA:20.77"],["1KQB_B_BEZB525_0","OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE","2wnb","-","Sus scrofa",4,"GLY A 273;SER A 325;THR A 328;PHE A 292","C5P A1344 (-3.2A);None;None;C5P A1344 (-4.6A)","1.32A","1kqbA-2wnbA:undetectable;1kqbB-2wnbA:undetectable","1kqbA-2wnbA:21.61;1kqbB-2wnbA:21.61"],["1SV9_A_DIFA701_1","PHOSPHOLIPASE A2","2wnb","-","Sus scrofa",5,"LEU A 263;ILE A 278;GLY A 273;HIS A 319;PHE A 212","None;None;C5P A1344 (-3.2A);GAL A1347 (-3.9A);GAL A1347 (-3.9A)","1.46A","1sv9A-2wnbA:undetectable","1sv9A-2wnbA:14.77"],["1V54_B_CHDB4085_0","CYTOCHROME C OXIDASE POLYPEPTIDE I;CYTOCHROME C OXIDASE POLYPEPTIDE II;CYTOCHROME C OXIDASE POLYPEPTIDE VIA-HEART","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.48A","1v54A-2wnbA:0.0;1v54B-2wnbA:0.0;1v54T-2wnbA:0.0","1v54A-2wnbA:17.88;1v54B-2wnbA:18.98;1v54T-2wnbA:14.73"],["2B17_A_DIFA701_1","PHOSPHOLIPASE A2 VRV-PL-VIIIA","2wnb","-","Sus scrofa",5,"LEU A 263;ILE A 278;GLY A 273;HIS A 319;PHE A 212","None;None;C5P A1344 (-3.2A);GAL A1347 (-3.9A);GAL A1347 (-3.9A)","1.46A","2b17A-2wnbA:undetectable","2b17A-2wnbA:14.77"],["2ZXW_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE 7A1;CYTOCHROME C OXIDASE SUBUNIT 1","2wnb","-","Sus scrofa",4,"ILE A  68;LEU A 281;PHE A  81;ARG A  60","None","1.15A","2zxwN-2wnbA:undetectable;2zxwW-2wnbA:undetectable","2zxwN-2wnbA:17.88;2zxwW-2wnbA:11.82"],["3ABK_O_CHDO229_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.48A","3abkG-2wnbA:0.0;3abkN-2wnbA:undetectable;3abkO-2wnbA:0.0","3abkG-2wnbA:14.73;3abkN-2wnbA:17.88;3abkO-2wnbA:18.98"],["3AG3_O_CHDO229_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.48A","3ag3G-2wnbA:undetectable;3ag3N-2wnbA:undetectable;3ag3O-2wnbA:undetectable","3ag3G-2wnbA:14.73;3ag3N-2wnbA:17.88;3ag3O-2wnbA:18.98"],["3AG4_B_CHDB1085_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.49A","3ag4A-2wnbA:0.0;3ag4B-2wnbA:0.0;3ag4T-2wnbA:0.0","3ag4A-2wnbA:17.88;3ag4B-2wnbA:18.98;3ag4T-2wnbA:14.73"],["3AG4_O_CHDO229_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.49A","3ag4G-2wnbA:0.0;3ag4N-2wnbA:0.0;3ag4O-2wnbA:0.0","3ag4G-2wnbA:14.73;3ag4N-2wnbA:17.88;3ag4O-2wnbA:18.98"],["3ASN_B_CHDB1085_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.45A","3asnA-2wnbA:0.0;3asnB-2wnbA:0.0;3asnT-2wnbA:0.0","3asnA-2wnbA:17.88;3asnB-2wnbA:18.98;3asnT-2wnbA:14.73"],["3ASO_B_CHDB1085_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.46A","3asoA-2wnbA:0.0;3asoB-2wnbA:0.0;3asoT-2wnbA:0.0","3asoA-2wnbA:17.88;3asoB-2wnbA:18.98;3asoT-2wnbA:14.73"],["3OI8_A_ADNA2_1","UNCHARACTERIZED PROTEIN","2wnb","-","Sus scrofa",4,"ILE A 120;HIS A 251;PRO A 211;LEU A 217","None","1.18A","3oi8A-2wnbA:undetectable","3oi8A-2wnbA:22.03"],["3U9F_K_CLMK221_0","CHLORAMPHENICOL ACETYLTRANSFERASE","2wnb","-","Sus scrofa",5,"PHE A 192;TYR A 250;PHE A 254;LEU A 289;VAL A 287","None","1.41A","3u9fK-2wnbA:undetectable","3u9fK-2wnbA:19.06"],["3W67_A_VIVA301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","2wnb","-","Sus scrofa",5,"LEU A 201;ILE A 208;VAL A 193;PHE A 198;VAL A 220","None","0.90A","3w67A-2wnbA:undetectable","3w67A-2wnbA:24.02"],["3W68_A_VIVA301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","2wnb","-","Sus scrofa",5,"LEU A 201;ILE A 208;VAL A 193;PHE A 198;VAL A 220","None","0.99A","3w68A-2wnbA:undetectable","3w68A-2wnbA:24.02"],["3W68_D_VIVD301_0","ALPHA-TOCOPHEROL TRANSFER PROTEIN","2wnb","-","Sus scrofa",5,"LEU A 201;ILE A 208;VAL A 193;PHE A 198;VAL A 220","None","0.98A","3w68D-2wnbA:undetectable","3w68D-2wnbA:24.02"],["3WG7_B_CHDB303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.43A","3wg7A-2wnbA:0.0;3wg7B-2wnbA:0.0;3wg7T-2wnbA:0.0","3wg7A-2wnbA:17.88;3wg7B-2wnbA:18.98;3wg7T-2wnbA:14.73"],["3WG7_G_CHDG103_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.46A","3wg7G-2wnbA:0.0;3wg7N-2wnbA:0.0;3wg7O-2wnbA:0.0","3wg7G-2wnbA:14.73;3wg7N-2wnbA:17.88;3wg7O-2wnbA:18.98"],["3X2Q_B_CHDB302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.50A","3x2qA-2wnbA:0.0;3x2qB-2wnbA:0.0;3x2qT-2wnbA:0.0","3x2qA-2wnbA:17.88;3x2qB-2wnbA:18.98;3x2qT-2wnbA:14.73"],["4MK4_B_CHDB502_0","FERROCHELATASE, MITOCHONDRIAL","2wnb","-","Sus scrofa",4,"PHE A 279;ILE A 283;ARG A 143;VAL A 131","None","1.01A","4mk4B-2wnbA:undetectable","4mk4B-2wnbA:21.37"],["4OBW_D_SAMD601_0","2-METHOXY-6-POLYPRENYL-1,4-BENZOQUINOL METHYLASE, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ALA A  91;GLY A 129;ILE A 120;ASN A 117;ASN A  93","None","1.25A","4obwD-2wnbA:undetectable","4obwD-2wnbA:20.71"],["4QZU_C_ACTC202_0","RETINOL-BINDING PROTEIN 2","2wnb","-","Sus scrofa",4,"TYR A 101;GLU A 218;THR A 119;LEU A 105","None","1.44A","4qzuC-2wnbA:undetectable","4qzuC-2wnbA:17.45"],["5B1A_B_CHDB303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.45A","5b1aA-2wnbA:0.0;5b1aB-2wnbA:0.0;5b1aT-2wnbA:0.0","5b1aA-2wnbA:17.88;5b1aB-2wnbA:18.98;5b1aT-2wnbA:14.73"],["5I8F_A_ML1A210_1","PHENOLIC OXIDATIVE COUPLING PROTEIN","2wnb","-","Sus scrofa",5,"LEU A 331;LEU A 263;VAL A 258;TYR A 250;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.42A","5i8fA-2wnbA:undetectable","5i8fA-2wnbA:21.48"],["5IY5_G_CHDG102_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.48A","5iy5G-2wnbA:0.0;5iy5N-2wnbA:0.0;5iy5O-2wnbA:0.0","5iy5G-2wnbA:14.78;5iy5N-2wnbA:17.88;5iy5O-2wnbA:18.98"],["5N0O_A_SAMA501_0","PEPTIDE N-METHYLTRANSFERASE","2wnb","-","Sus scrofa",5,"ILE A 278;VAL A 147;SER A 276;PHE A 292;VAL A 327","None;None;None;C5P A1344 (-4.6A);None","1.16A","5n0oA-2wnbA:undetectable","5n0oA-2wnbA:22.25"],["5N0S_B_SAMB501_0","PEPTIDE N-METHYLTRANSFERASE","2wnb","-","Sus scrofa",5,"ILE A 278;VAL A 147;SER A 276;PHE A 292;VAL A 327","None;None;None;C5P A1344 (-4.6A);None","1.18A","5n0sB-2wnbA:undetectable","5n0sB-2wnbA:22.28"],["5ND3_B_TA1B601_1","TUBULIN BETA-2B CHAIN","2wnb","-","Sus scrofa",5,"VAL A 242;GLU A 200;LEU A 217;LEU A 209;THR A 215","None","1.26A","5nd3B-2wnbA:undetectable","5nd3B-2wnbA:20.65"],["5W97_B_CHDB303_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.49A","5w97A-2wnbA:0.0;5w97B-2wnbA:0.0;5w97g-2wnbA:0.0","5w97A-2wnbA:17.88;5w97B-2wnbA:18.98;5w97g-2wnbA:14.73"],["5X1F_G_CHDG104_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.48A","5x1fG-2wnbA:0.0;5x1fN-2wnbA:0.0;5x1fO-2wnbA:0.0","5x1fG-2wnbA:14.73;5x1fN-2wnbA:17.88;5x1fO-2wnbA:18.98"],["5XDQ_B_CHDB304_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.49A","5xdqA-2wnbA:0.0;5xdqB-2wnbA:0.0;5xdqT-2wnbA:0.0","5xdqA-2wnbA:17.88;5xdqB-2wnbA:18.98;5xdqT-2wnbA:14.73"],["5XDQ_G_CHDG102_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.48A","5xdqG-2wnbA:0.0;5xdqN-2wnbA:0.0;5xdqO-2wnbA:0.0","5xdqG-2wnbA:14.73;5xdqN-2wnbA:17.88;5xdqO-2wnbA:18.98"],["5XDX_B_CHDB302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.49A","5xdxA-2wnbA:0.0;5xdxB-2wnbA:0.0;5xdxT-2wnbA:0.0","5xdxA-2wnbA:17.88;5xdxB-2wnbA:18.98;5xdxT-2wnbA:14.73"],["5XDX_O_CHDO301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.46A","5xdxG-2wnbA:0.0;5xdxN-2wnbA:0.0;5xdxO-2wnbA:0.0","5xdxG-2wnbA:14.73;5xdxN-2wnbA:17.88;5xdxO-2wnbA:18.98"],["5ZCO_B_CHDB302_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.49A","5zcoA-2wnbA:0.0;5zcoB-2wnbA:0.0;5zcoT-2wnbA:0.0","5zcoA-2wnbA:17.88;5zcoB-2wnbA:18.98;5zcoT-2wnbA:14.73"],["5ZCO_G_CHDG102_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"ARG A 171;PHE A 192;GLY A 273;GLY A 291;THR A 328","None;None;C5P A1344 (-3.2A);None;None","1.49A","5zcoG-2wnbA:0.0;5zcoN-2wnbA:0.0;5zcoO-2wnbA:0.0","5zcoG-2wnbA:14.73;5zcoN-2wnbA:17.88;5zcoO-2wnbA:18.98"],["5ZCP_B_CHDB301_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 2;CYTOCHROME C OXIDASE SUBUNIT 6A2, MITOCHONDRIAL","2wnb","-","Sus scrofa",5,"GLY A 291;THR A 328;ARG A 171;PHE A 192;GLY A 273","None;None;None;None;C5P A1344 (-3.2A)","1.50A","5zcpA-2wnbA:0.0;5zcpB-2wnbA:0.0;5zcpT-2wnbA:0.0","5zcpA-2wnbA:17.88;5zcpB-2wnbA:18.98;5zcpT-2wnbA:14.73"]]